Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Leipzig
Clinical trial register · Germany

Clinical Trials in Leipzig, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Germany and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5087 matching records held by the registry are in this view. Synced 20 Nov 2026, 03:18 UTC
5087
Studies in scope
all four open statuses
2894
Recruiting now
open to new participants
991
Lead sponsors
across recruiting studies
Top sites
Erlangen 2 Leipzig 2 Chemnitz 2 Augsburg 2 Bayreuth 1
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca26 Eli Lilly and Company23 Novartis Pharmaceuticals21 University of Leipzig20 Pfizer15 Janssen Research & Development, LLC15 Sanofi13 GlaxoSmithKline10 Bristol-Myers Squibb9 Novo Nordisk A/S9 Merck Sharp & Dohme LLC8 Abbott Medical Devices7 Hoffmann-La Roche7 AbbVie7 Takeda7 Boehringer Ingelheim6 Medtronic Cardiovascular5 Regeneron Pharmaceuticals5 Amgen4 Heart Center Leipzig - University Hospital4 EMD Serono Research & Development Institute, Inc.4 European Organisation for Research and Treatment of Cancer - EORTC4 Juno Therapeutics, Inc., a Bristol-Myers Squibb Company4 Daiichi Sankyo4 University Hospital Tuebingen4 Leipzig Heart Science gGmbH4 Technische Universität Dresden3 Max Planck Institute for Human Cognitive and Brain Sciences3 CSL Behring3 Population Health Research Institute3 Edwards Lifesciences3 Genmab3 AO Innovation Translation Center3 Helios Health Institute GmbH3 Astellas Pharma Global Development, Inc.3 Celgene3 Ipsen3 BeOne Medicines2 Promedon2 Akero Therapeutics, Inc2 Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest2 Prof. Dr. Martin Wabitsch2 University Hospital of Cologne2 Stemline Therapeutics, Inc.2 Alnylam Pharmaceuticals2 Syndax Pharmaceuticals2 Medtronic Cardiac Surgery2 Charite University, Berlin, Germany2 Alfasigma S.p.A.2 Krankenhaus Nordwest2 Geron Corporation2 Travere Therapeutics, Inc.2 Camurus AB2 ReCor Medical, Inc.2 Viatris Innovation GmbH2 Incyte Corporation2 Chiesi Farmaceutici S.p.A.2 Biotronik SE & Co. KG2 Mirum Pharmaceuticals, Inc.2 Philogen S.p.A.2 Ottawa Heart Institute Research Corporation2 Leipzig University Medical Center2 UCB Biopharma SRL2 Institut de Recherches Internationales Servier2 GRIN Therapeutics, Inc.2 Madrigal Pharmaceuticals, Inc.2 Agios Pharmaceuticals, Inc.2 Medtronic Vascular2 Deciphera Pharmaceuticals, LLC1 V-Wave Ltd1 Windward Bio1 Alpine Immune Sciences Inc, A Subsidiary of Vertex1 Stichting European Myeloma Network1 ReFlow Medical, Inc.1 St. Antonius Hospital Gronau1 Beijing InnoCare Pharma Tech Co., Ltd.1 Priothera SAS1 Vertex Pharmaceuticals Incorporated1 Mathys Ltd Bettlach1 Sophia Genetics SAS1 Medical University Innsbruck1 Michael Hoelscher1 Imricor Medical Systems1 Stefan Hagel1 University Hospital Freiburg1 Dren Bio1 Genentech, Inc.1 EspeRare Foundation1 Marc Bosiers, MD1 GLYCAR SA (Pty) Ltd1 medac GmbH1 Cardiovascular and Interventional Radiological Society of Europe1 Eclipse Medical Ltd.1 National Cancer Institute (NCI)1 Kyowa Kirin Pharmaceutical Development Ltd1 Bluefin Biomedicine, Inc.1 GWT-TUD GmbH1 Shockwave Medical, Inc.1 Avalyn Pharma Inc.1 University Hospital Goettingen1 Thomas Ernst, Prof. Dr. med.1 Corbus Pharmaceuticals Inc.1 BioTex, Inc.1 Orphalan1 Shape Memory Medical, Inc.1 Universitätsmedizin Mannheim1 CytoSorbents, Inc1 European Clinical Research Alliance for Infectious Diseases (ECRAID)1 Sellas Life Sciences Group1 OncoVerity, Inc.1 Janssen Pharmaceutica N.V., Belgium1 Meril Life Sciences Pvt. Ltd.1 Loxo Oncology, Inc.1 Hamilton Health Sciences Corporation1 Bayer1 University of Cologne1 Worcester Polytechnic Institute1 Alentis Therapeutics AG1 Spyre Therapeutics, Inc.1 Association for Innovation and Biomedical Research on Light and Image1 Lisette Nixon1 MaaT Pharma1 LMU Klinikum1 University Hospital Schleswig-Holstein1 Insel Gruppe AG, University Hospital Bern1 Janssen Biotech, Inc.1 Target PharmaSolutions, Inc.1 Massachusetts General Hospital1 Institut für Pharmakologie und Präventive Medizin1 Philip Morris Products S.A.1 The Lymphoma Academic Research Organisation1 Tobias Feuchtinger1 Ascentage Pharma Group Inc.1 Penumbra Inc.1 HUYABIO International, LLC.1 OHB Neonatology Ltd.1 Delcath Systems Inc.1 Jena University Hospital1 Vivasure Medical Limited1 Acotec Scientific Co., Ltd1 Actelion1 Nektar Therapeutics1 4TEEN4 Pharmaceuticals GmbH1 Alumis Inc1 LeMaitre Vascular1 Goethe University1 University of Ulm1 Ascletis Pharma (China) Co., Limited1 Contura1 SecuraBio1 Mineralys Therapeutics Inc.1 Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany1 Boris Böll1 MedSIR1 Kailera1 Aragon Pharmaceuticals, Inc.1 Deepull Diagnostics S.L.1 Biosensors Europe SA1 Upstream Bio Inc.1 Copenhagen University Hospital, Rigshospitalet1 Kymera Therapeutics, Inc.1 Vascutek Ltd.1 Asklepios proresearch1 Christian Schulze1 University Medical Center Groningen1 Seagen, a wholly owned subsidiary of Pfizer1 Miltenyi Biomedicine GmbH1 CVRx, Inc.1 Biogen1 ABX advanced biochemical compounds GmbH1 Genetix Biotherapeutics Inc.1 Zealand Pharma1 Gilead Sciences1 Artcline GmbH1 Sequana Medical N.V.1 Lexicon Pharmaceuticals1 Rijnstate Hospital1 Artivion Inc.1 Weill Medical College of Cornell University1 GCP-Service International West GmbH1 University Hospital Augsburg1 Blueprint Medicines Corporation1 Prof. Dr. Frank Behrens1 HighLife SAS1 Pneumonia Research Network on Genetic Resistance and Susceptibility for the Evolution of Severe Seps1 Orchestra BioMed, Inc1 Innoventric LTD1 W.L.Gore & Associates1 Inventiva Pharma1 Annetine Gelijns1 University Hospital Muenster1 Kite, A Gilead Company1 Assistance Publique - Hôpitaux de Paris1 Trans-Duodenal Concepts GmbH1 BioNTech SE1 Sunnybrook Health Sciences Centre1 Micro Medical Solution, Inc.1 Atea Pharmaceuticals, Inc.1 Teva Branded Pharmaceutical Products R&D LLC1 REVA Medical, Inc.1 Alexion Pharmaceuticals, Inc.1 Anocca AB1 Inari Medical1 Boston Scientific Corporation1 Galecto Biotech AB1 Minoryx Therapeutics, S.L.1 Western Sydney Local Health District1 M.A. Med Alliance S.A.1 Neurocrine Biosciences1 BioMarin Pharmaceutical1 University Hospital, Geneva1 Corxel Pharmaceuticals1 Octapharma1 Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)1 Swedish Orphan Biovitrum1 iVascular S.L.U.1 Shenzhen Core Medical Technology CO.,LTD.1 Karyopharm Therapeutics Inc1 TME Pharma AG1 Intressa Vascular SA1 Intensity Therapeutics, Inc.1 Generate Biomedicines1 University Hospital, Basel, Switzerland1 Federation Francophone de Cancerologie Digestive1 Ivy Brain Tumor Center1 FCRE (Foundation for Cardiovascular Research and Education)1 Day One Biopharmaceuticals, Inc.1 Vanda Pharmaceuticals1 Universitätsklinikum Hamburg-Eppendorf1 Lifetech Scientific (Shenzhen) Co., Ltd.1 United Therapeutics1 Aptose Biosciences Inc.1 Contego Medical, Inc.1 SoniVie Inc.1 Zimmer Biomet1 University of Giessen1 Technical University of Munich1 University Hospital, Antwerp1 Clear sponsor filter
Target enrolment
to

Trials with a site in Leipzig

2 of 5087 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
Recruiting
A Non-interventional Study of Participants With BPDCN Treated With Chemotherapy
NCT07785180Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Stemline Therapeutics, Inc.
Observational
140
Bremen, Chemnitz, Leipzig, Lübeck, Munich, Oldenburg, Würzburg
2025-10-17
Recruiting
Stemline Therapeutics, Inc.
Phase 1/2
73
Bayreuth, Cologne, Dresden, Düsseldorf, Erlangen, Hanover, Leipzig, Worms
2022-08-31
Rows per page Showing 1–2 of 2
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a German investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 20 November 2026. https://priyalifescience.com/clinical-trials-germany/city/leipzig

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Germany and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,087 studies in total at the last sync on 20 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 2 of those studies with a site in Leipzig that also match the filters currently applied.

How many clinical trials are recruiting in Leipzig?

2 of the 2 studies on this page are recruiting new participants as of the 20 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Leipzig), 2 studies
PhaseStudiesRecruitingShare
Observational1150%
Phase 1/21150%

Most active sponsors

Lead sponsors with the most studies (Leipzig)
Lead sponsorStudiesRecruiting
Stemline Therapeutics, Inc.22
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.